@article{ref1,
title="Hidradenitis Suppurativa--Diagnosis and Management",
journal="Journal for nurse practitioners, The",
year="2019",
author="Hood, C. and Shanmugam, V.K.",
volume="15",
number="10",
pages="713-716",
abstract="Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease that is estimated to affect up to 4% of the population. Patients with HS are at increased risk for anxiety, depression, and suicide. Despite the prevalence of this disease, there is still underrecognition and often a delay in diagnosis. For successful treatment, a multimodal approach is recommended. Effective treatments include excision surgery, tumor necrosis factor (TNF) inhibitor therapy, antibiotics, hormonal therapy, and metformin. Supportive treatments such as wound care, effective pain management, and advising on weight loss and smoking cessation are also important components of successful disease management. © 2019 Elsevier Inc.<p /><p>Language: en</p>",
language="en",
issn="1555-4155",
doi="10.1016/j.nurpra.2019.07.004",
url="http://dx.doi.org/10.1016/j.nurpra.2019.07.004"
}